List Title | APhA DrugInfoLine

Infectious Diseases

SORT BY: Most Recent Most Viewed

November 1, 2000

Chickenpox Vaccine Prevents Complications in Older Patients

READ

PREVIEW
Adults who never have had chickenpox should be vaccinated against it. Once vaccinated, serious chickenpox infections and related complications are minimized, and the effects of the vaccine are...
October 1, 2000

Latent TB Infections: Changes in Testing, Treatment

READ

PREVIEW
New CDC recommendations emphasize targeted testing for tuberculosis (TB) and formally endorses short courses of rifampin (Rifadin—Aventis) for treatment of latent TB infections.
August 1, 2000

New Drugs, New Ideas Presented at AIDS Conference

READ

PREVIEW
Patients whose HIV infections are in remission may benefit from cyclic therapy, in which periods of pharmacotherapy are interrupted by drug holidays. These and many other new concepts were...
July 1, 2000

Antibiotic Resistance: Focusing on Patients, Pharmacists

READ

PREVIEW
As clinicians struggle to maintain effectiveness of antibiotics for serious pathogens, a variety of social, cultural, and economic factors are compromising care. Two recently published articles...
June 1, 2000

Linezolid Adds Important Agent for Difficult-to-Treat Infections

READ

PREVIEW
The first agent in a completely new class of antibiotics—linezolid (Zyvox—Pharmacia)— is indicated for treatment of problematic gram-positive pathogens. The antibiotic, with...

Pages

Medication Monitor

RSS Follow Medication Monitor on Twitter Follow APhA Druginfoline on Twitter

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.